Interestingly, the majority (>55%) of such service providers firms are based in Europe

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

§  Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

§  Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

§  Type of Drug Molecule

§  Biologics 

§  Small Molecule

§  Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

To Request for sample report -  https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html

Table of Contents

1. Preface

2. Executive Summary

3. Introduction
 

4. Market Landscape
 

5. Role of Non-Profit / Academic Organizations

6. Company Profiles
 

7.  Partnerships
 

8. Big Pharma Initiatives
 

9. Case Study: Discontinued Drug Development Programs
 

10. Cost Saving Analysis
 

11. Market Forecast and Opportunity Analysis
 

12.  Covid-19 Impact on Drug Repurposing Service Providers Market
 

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing

14. Interview Transcripts

15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing

16. Appendix 2: Tabulated Data

17. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

Other Recent Offerings

1.      Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition), 2021-2030

2.      Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030

3.      Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Article source: https://article-realm.com/article/Health-Fitness/Exercise/15274-Interestingly-the-majority-55-of-such-service-providers-firms-are-based-in-Europe.html